We’re thrilled to share a milestone that feels both humbling and surreal: CurifyLabs has been selected as the winner of the 2025 “Productive Idea” award arranged by JCI (Junior Chamber International) — the very same recognition that ŌURA received just a few years ago. To follow in the footsteps of such an iconic Finnish innovator is an honour we will carry proudly into the future.
As part of the prize, CurifyLabs received a truly unforgettable spotlight:
🌟 Our company was featured on Times Square in New York,
and
🔔 Our CEO and Founder, Charlotta Topelius had the rare privilege of ringing the Nasdaq Helsinki bell
This award is more than a trophy; it’s a powerful validation of what we’ve set out to do at CurifyLabs. Transforming pharmaceutical compounding is a bold mission — one that requires conviction, creativity, and courage. To have this work recognized on an international stage is an energizing reminder that our efforts matter.
Thank you to the judges — Petra Eratuli, Siamäk Naghian, and Erja Retzén — for believing in our vision and seeing the potential in what we’re building. And a special shout-out to Viivi Moberg (Naatula) for signing us up for this adventure in the first place — without you, this moment wouldn’t have existed. 💛
Warm thanks as well to Minja Mikola for the invaluable support throughout the process.
Recognition like this means the world to an entrepreneurial hearts. 🚀 We’re more inspired than ever to continue our work toward a future where pharmaceutical compounding is modern, precise, and accessible everywhere it’s needed.
Onwards — and thank you for celebrating this journey with us.